Filing Details
- Accession Number:
- 0000945769-12-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-18 10:38:36
- Reporting Period:
- 2012-07-16
- Filing Date:
- 2012-07-18
- Accepted Time:
- 2012-07-18 10:38:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887497 | Hi Tech Pharmacal Co Inc | HITK | Pharmaceutical Preparations (2834) | 112638720 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1263136 | J William Peters | C/O Hi-Tech Pharmacal Co., Inc. 369 Bayview Avenue Amityville NY 11701 | Vp And Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-16 | 4,983 | $19.95 | 4,983 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-07-16 | 4,983 | $32.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-07-16 | 4,983 | $0.00 | 4,983 | $19.95 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2012-07-16 | 30,000 | $0.00 | 30,000 | $32.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2004-09-08 | 2013-09-08 | No | 4 | M | Direct |
30,000 | 2013-07-16 | 2022-07-16 | No | 4 | A | Direct |
Footnotes
- The option exercise and open market sale were made pursuant to a 10b5-1 trading plan adopted by the filer in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
- Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a Rule 16b-3 Plan.
- The option became or becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
- Other than the option to acquire 30,000 shares reflected on this form as acquired by the filer as a result of the option grant, the filer is also the holder of additional options to acquire 123,750 shares of Hi-Tech Common Stock (for aggregate options to acquire a total of 153,750 shares of Common Stock), which options were granted on various dates, with varying exercise prices and exercisable and expiration dates.